Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| PACS Group, Inc.PACS · Entity 2590 | Director · 10% owner | September 14, 2026 | September 15, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
PACS Group, Inc.
Report date September 14, 2026 · Filed September 15, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 53,518,884 |
Ending reported balance
After 2026-09-15 transaction · row 5
5 source rows · reconciled sequenceRow 1 · 2026-09-14 · Sale · Disposed 137,684 · Balance 53,681,200 F1: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 11, 2026. F2: The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $43.885 to $44.8845 per share of common stock. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Row 2 · 2026-09-14 · Sale · Disposed 6,634 · Balance 53,674,566 F1: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 11, 2026. F3: The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $44.885 to $45.13 per share of common stock. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Row 3 · 2026-09-15 · Sale · Disposed 104,132 · Balance 53,570,434 F1: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 11, 2026. F4: The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $41.47 to $42.465 per share of common stock. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Row 4 · 2026-09-15 · Sale · Disposed 30,466 · Balance 53,539,968 F1: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 11, 2026. F5: The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $42.47 to $43.4628 per share of common stock. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Row 5 · 2026-09-15 · Sale · Disposed 21,084 · Balance 53,518,884 F1: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 11, 2026. F6: The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $43.51 to $44.435 per share of common stock. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
Filing footnotes · ownership attribution and instrument terms
F1: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 11, 2026.
F2: The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $43.885 to $44.8845 per share of common stock. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F3: The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $44.885 to $45.13 per share of common stock. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F4: The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $41.47 to $42.465 per share of common stock. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F5: The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $42.47 to $43.4628 per share of common stock. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F6: The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $43.51 to $44.435 per share of common stock. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 15, 2026 Filed Sep 15, 2026 22:00 UTC | PACS Group, Inc. PACS · Entity 2590 | SaleCommon Stock | 21,084 | $43.75 | $922,393.37 |
DisclosureSEC source: 0002014361-26-000035 · wk-form4_1789509636.xml · nonDerivative · entry 5 Hancock Mark · CIK 0002014361 · Director · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 53,518,884 F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 11, 2026. F6 · price: The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $43.51 to $44.435 per share of common stock. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| September 15, 2026 Filed Sep 15, 2026 22:00 UTC | PACS Group, Inc. PACS · Entity 2590 | SaleCommon Stock | 30,466 | $42.89 | $1,306,647.13 |
DisclosureSEC source: 0002014361-26-000035 · wk-form4_1789509636.xml · nonDerivative · entry 4 Hancock Mark · CIK 0002014361 · Director · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 53,539,968 F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 11, 2026. F5 · price: The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $42.47 to $43.4628 per share of common stock. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| September 15, 2026 Filed Sep 15, 2026 22:00 UTC | PACS Group, Inc. PACS · Entity 2590 | SaleCommon Stock | 104,132 | $42.09 | $4,382,988.77 |
DisclosureSEC source: 0002014361-26-000035 · wk-form4_1789509636.xml · nonDerivative · entry 3 Hancock Mark · CIK 0002014361 · Director · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 53,570,434 F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 11, 2026. F4 · price: The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $41.47 to $42.465 per share of common stock. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| September 14, 2026 Filed Sep 15, 2026 22:00 UTC | PACS Group, Inc. PACS · Entity 2590 | SaleCommon Stock | 6,634 | $44.91 | $297,901.10 |
DisclosureSEC source: 0002014361-26-000035 · wk-form4_1789509636.xml · nonDerivative · entry 2 Hancock Mark · CIK 0002014361 · Director · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 53,674,566 F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 11, 2026. F3 · price: The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $44.885 to $45.13 per share of common stock. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| September 14, 2026 Filed Sep 15, 2026 22:00 UTC | PACS Group, Inc. PACS · Entity 2590 | SaleCommon Stock | 137,684 | $44.56 | $6,134,951.21 |
DisclosureSEC source: 0002014361-26-000035 · wk-form4_1789509636.xml · nonDerivative · entry 1 Hancock Mark · CIK 0002014361 · Director · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 53,681,200 F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 11, 2026. F2 · price: The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $43.885 to $44.8845 per share of common stock. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| August 18, 2026 Filed Aug 27, 2026 22:50 UTC | PACS Group, Inc. PACS · Entity 2590 | GiftCommon Stock | 88,000 | $0.00 | $0.00 |
DisclosureSEC source: 0002014361-26-000032 · wk-form4_1787871035.xml · nonDerivative · entry 1 Hancock Mark · CIK 0002014361 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 53,818,884 F1 · kind: Represents a bona fide gift made by the Reporting Person to a charitable donor-advised fund. Read SEC document |
| July 15, 2026 Filed Jul 16, 2026 22:12 UTC | PACS Group, Inc. PACS · Entity 2590 | SaleCommon Stock | 3,332 | $45.05 | $150,114.93 |
DisclosureSEC source: 0002014361-26-000030 · wk-form4_1784239931.xml · nonDerivative · entry 2 Hancock Mark · CIK 0002014361 · Director · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 53,906,884 F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 11, 2026. F3 · price: The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $45.00 to $45.07 per share of common stock. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| July 14, 2026 Filed Jul 16, 2026 22:12 UTC | PACS Group, Inc. PACS · Entity 2590 | SaleCommon Stock | 10,296 | $45.04 | $463,680.36 |
DisclosureSEC source: 0002014361-26-000030 · wk-form4_1784239931.xml · nonDerivative · entry 1 Hancock Mark · CIK 0002014361 · Director · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 53,910,216 F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 11, 2026. F2 · price: The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $45.00 to $45.1727 per share of common stock. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| July 09, 2026 Filed Jul 10, 2026 22:18 UTC | PACS Group, Inc. PACS · Entity 2590 | SaleCommon Stock | 4,966 | $45.06 | $223,781.37 |
DisclosureSEC source: 0002014361-26-000026 · wk-form4_1783721889.xml · nonDerivative · entry 2 Hancock Mark · CIK 0002014361 · Director · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 53,920,512 F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 11, 2026. F3 · price: The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $45.00 to $45.255 per share of common stock. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| July 08, 2026 Filed Jul 10, 2026 22:18 UTC | PACS Group, Inc. PACS · Entity 2590 | SaleCommon Stock | 20,338 | $45.07 | $916,611.29 |
DisclosureSEC source: 0002014361-26-000026 · wk-form4_1783721889.xml · nonDerivative · entry 1 Hancock Mark · CIK 0002014361 · Director · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 53,925,478 F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 11, 2026. F2 · price: The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $45.00 to $45.2861 per share of common stock. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| July 06, 2026 Filed Jul 6, 2026 22:50 UTC | PACS Group, Inc. PACS · Entity 2590 | SaleCommon Stock | 142,163 | $45.33 | $6,444,860.09 |
DisclosureSEC source: 0002014361-26-000022 · wk-form4_1783378209.xml · nonDerivative · entry 4 Hancock Mark · CIK 0002014361 · Director · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 53,945,816 F2 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 11, 2026. F5 · price: The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $45.00 to $45.88 per share of common stock. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| July 02, 2026 Filed Jul 6, 2026 22:50 UTC | PACS Group, Inc. PACS · Entity 2590 | SaleCommon Stock | 12,825 | $45.01 | $577,290.44 |
DisclosureSEC source: 0002014361-26-000022 · wk-form4_1783378209.xml · nonDerivative · entry 3 Hancock Mark · CIK 0002014361 · Director · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 54,087,979 F2 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 11, 2026. F4 · price: The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $45.00 to $45.115 per share of common stock. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| July 01, 2026 Filed Jul 6, 2026 22:50 UTC | PACS Group, Inc. PACS · Entity 2590 | SaleCommon Stock | 6,080 | $45.02 | $273,716.13 |
DisclosureSEC source: 0002014361-26-000022 · wk-form4_1783378209.xml · nonDerivative · entry 2 Hancock Mark · CIK 0002014361 · Director · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 54,100,804 F2 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 11, 2026. F3 · price: The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $45.00 to $45.075 per share of common stock. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| July 01, 2026 Filed Jul 6, 2026 22:50 UTC | PACS Group, Inc. PACS · Entity 2590 | GrantCommon Stock | 4,287 | $0.00 | $0.00 |
DisclosureSEC source: 0002014361-26-000022 · wk-form4_1783378209.xml · nonDerivative · entry 1 Hancock Mark · CIK 0002014361 · Director · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 54,106,884 F1 · shares: Represents restricted stock units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of Common Stock for each RSU upon vesting. 100% of the RSUs will vest on the earlier to occur of (i) July 1, 2027 and (ii) the date of the next annual meeting following the grant date, subject to the Reporting Person's continued service to the Issuer. Read SEC document |
| June 26, 2026 Filed Jun 26, 2026 22:12 UTC | PACS Group, Inc. PACS · Entity 2590 | SaleCommon Stock | 200 | $41.01 | $8,202.00 |
DisclosureSEC source: 0002014361-26-000017 · wk-form4_1782511938.xml · nonDerivative · entry 3 Hancock Mark · CIK 0002014361 · Director · Co Fndr; Exec V Chair · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 54,102,597 F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 11, 2026. Read SEC document |
| June 26, 2026 Filed Jun 26, 2026 22:12 UTC | PACS Group, Inc. PACS · Entity 2590 | SaleCommon Stock | 61,731 | $40.50 | $2,499,883.27 |
DisclosureSEC source: 0002014361-26-000017 · wk-form4_1782511938.xml · nonDerivative · entry 2 Hancock Mark · CIK 0002014361 · Director · Co Fndr; Exec V Chair · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 54,102,797 F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 11, 2026. F3 · price: The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $40.01 to $41.0016 per share of common stock. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| June 25, 2026 Filed Jun 26, 2026 22:12 UTC | PACS Group, Inc. PACS · Entity 2590 | SaleCommon Stock | 138,069 | $40.33 | $5,567,701.46 |
DisclosureSEC source: 0002014361-26-000017 · wk-form4_1782511938.xml · nonDerivative · entry 1 Hancock Mark · CIK 0002014361 · Director · Co Fndr; Exec V Chair · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 54,164,528 F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 11, 2026. F2 · price: The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $40.00 to $40.67 per share of common stock. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| June 17, 2026 Filed Jun 22, 2026 23:02 UTC | PACS Group, Inc. PACS · Entity 2590 | SaleCommon Stock | 3,316 | $35.75 | $118,544.02 |
DisclosureSEC source: 0002014361-26-000013 · wk-form4_1782169369.xml · nonDerivative · entry 2 Hancock Mark · CIK 0002014361 · Director · Co Fndr; Exec V Chair · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 54,302,597 F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 11, 2026. F3 · price: The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $35.6799 to $36.0685 per share of common stock. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| June 17, 2026 Filed Jun 22, 2026 23:02 UTC | PACS Group, Inc. PACS · Entity 2590 | SaleCommon Stock | 60,364 | $35.28 | $2,129,871.30 |
DisclosureSEC source: 0002014361-26-000013 · wk-form4_1782169369.xml · nonDerivative · entry 1 Hancock Mark · CIK 0002014361 · Director · Co Fndr; Exec V Chair · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 54,305,913 F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 11, 2026. F2 · price: The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $34.6757 to $35.67 per share of common stock. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| June 16, 2026 Filed Jun 17, 2026 20:32 UTC | PACS Group, Inc. PACS · Entity 2590 | SaleCommon Stock | 83,066 | $35.90 | $2,982,385.05 |
DisclosureSEC source: 0002014361-26-000010 · wk-form4_1781728338.xml · nonDerivative · entry 4 Hancock Mark · CIK 0002014361 · Director · Co Fndr; Exec V Chair · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 54,366,277 F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 11, 2026. F4 · price: The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $35.62 to $36.49 per share of common stock. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| June 15, 2026 Filed Jun 17, 2026 20:32 UTC | PACS Group, Inc. PACS · Entity 2590 | SaleCommon Stock | 23 | $37.88 | $871.14 |
DisclosureSEC source: 0002014361-26-000010 · wk-form4_1781728338.xml · nonDerivative · entry 3 Hancock Mark · CIK 0002014361 · Director · Co Fndr; Exec V Chair · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 54,449,343 F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 11, 2026. Read SEC document |
| June 15, 2026 Filed Jun 17, 2026 20:32 UTC | PACS Group, Inc. PACS · Entity 2590 | SaleCommon Stock | 19,138 | $37.05 | $709,145.19 |
DisclosureSEC source: 0002014361-26-000010 · wk-form4_1781728338.xml · nonDerivative · entry 2 Hancock Mark · CIK 0002014361 · Director · Co Fndr; Exec V Chair · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 54,449,366 F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 11, 2026. F3 · price: The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $36.84 to $37.445 per share of common stock. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| June 15, 2026 Filed Jun 17, 2026 20:32 UTC | PACS Group, Inc. PACS · Entity 2590 | SaleCommon Stock | 134,093 | $36.23 | $4,858,739.17 |
DisclosureSEC source: 0002014361-26-000010 · wk-form4_1781728338.xml · nonDerivative · entry 1 Hancock Mark · CIK 0002014361 · Director · Co Fndr; Exec V Chair · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 54,468,504 F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 11, 2026. F2 · price: The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $35.84 to $36.835 per share of common stock. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| March 24, 2026 Filed Mar 26, 2026 22:11 UTC | PACS Group, Inc. PACS · Entity 2590 | GrantCommon Stock | 98,154 | $0.00 | $0.00 |
DisclosureSEC source: 0002014361-26-000006 · wk-form4_1774563070.xml · nonDerivative · entry 1 Hancock Mark · CIK 0002014361 · Director · Co Fndr; Int CFO; Exec V Chair · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 54,602,597 F1 · shares: Represents restricted stock units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of Common Stock for each RSU upon vesting. The RSUs will vest in substantially equal annual installments on the first, second, and third anniversaries of March 24, 2026, subject to the Reporting Person's continued service through the applicable vesting date. Read SEC document |
| March 05, 2026 Filed Mar 9, 2026 22:30 UTC | PACS Group, Inc. PACS · Entity 2590 | GiftCommon Stock | 300,000 | $0.00 | $0.00 |
DisclosureSEC source: 0002014361-26-000004 · wk-form4_1773095434.xml · nonDerivative · entry 1 Hancock Mark · CIK 0002014361 · Director · Co Fndr; Int CFO; Exec V Chair · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 54,504,443 F1 · kind: Represents a bona fide gift made by the Reporting Person to a charitable donor-advised fund. Read SEC document |
| January 15, 2026 Filed Jan 20, 2026 21:56 UTC | PACS Group, Inc. PACS · Entity 2590 | Tax withholdingCommon Stock | 12,774 | $39.49 | $504,445.26 |
DisclosureSEC source: 0002014361-26-000002 · wk-form4_1768946205.xml · nonDerivative · entry 1 Hancock Mark · CIK 0002014361 · Director · Co Fndr; Int CFO; Exec V Chair · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 54,804,443 F1 · kind: Payment of tax liability through the withholding of securities upon the vesting of previously granted and reported restricted stock units. Read SEC document |
| December 17, 2025 Filed Dec 19, 2025 21:30 UTC | PACS Group, Inc. PACS · Entity 2590 | GrantCommon Stock | 41,018 | $0.00 | $0.00 |
DisclosureSEC source: 0002014361-25-000004 · wk-form4_1766179852.xml · nonDerivative · entry 2 Hancock Mark · CIK 0002014361 · Director · Co Fndr; Int CFO; Exec V Chair · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 54,817,217 F2 · shares: Represents RSUs for which the Reporting Person is entitled to receive one (1) share of Common Stock for each RSU upon vesting. The RSUs will vest in substantially equal annual installments on the first, second, and third anniversaries of November 25, 2025, subject to the Reporting Person's continued service through the applicable vesting date. Read SEC document |
| December 17, 2025 Filed Dec 19, 2025 21:30 UTC | PACS Group, Inc. PACS · Entity 2590 | GrantCommon Stock | 150,000 | $0.00 | $0.00 |
DisclosureSEC source: 0002014361-25-000004 · wk-form4_1766179852.xml · nonDerivative · entry 1 Hancock Mark · CIK 0002014361 · Director · Co Fndr; Int CFO; Exec V Chair · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 54,776,199 F1 · shares: Represents restricted stock units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of Common Stock for each RSU upon vesting. The RSUs will vest in substantially equal annual installments on the first, second, and third anniversaries of January 15, 2025, subject to the Reporting Person's continued service through the applicable vesting date. Read SEC document |
| September 09, 2024 Filed Sep 10, 2024 20:01 UTC | PACS Group, Inc. PACS · Entity 2590 | SaleCommon Stock | 8,128,352 | $36.25 | $294,652,760.00 |
DisclosureSEC source: 0001628280-24-040015 · wk-form4_1725998510.xml · nonDerivative · entry 1 Hancock Mark · CIK 0002014361 · Director · Co-Founder & Exec. Vice Chair. · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 45,126,199 Read SEC document |
| April 15, 2024 Filed Apr 15, 2024 20:02 UTC | PACS Group, Inc. PACS · Entity 2590 | SaleCommon Stock | 1,607,142 | $21.00 | $33,749,982.00 |
DisclosureSEC source: 0001628280-24-016204 · wk-form4_1713211352.xml · nonDerivative · entry 1 Hancock Mark · CIK 0002014361 · Director · Co-Founder & Exec. Vice Chair. · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 62,754,551 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.